Hjem › Autoimmune sykdommer › Michigan
Kliniske studier for Autoimmune sykdommer i Michigan
9 studier for Autoimmune sykdommer søker deltakere på steder i Michigan.
Byer i Michigan
Offisiell studietekst (engelsk)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Clinical Research Inst of MI, Saint Clair Shores
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07621809Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
- University of Michigan, Ann Arbor
RekruttererObservasjonsstudie
1 Month – 100 Years · Alle kjønn · Oppdatert 24. sep. 2026 · NCT00246857RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- University of Michigan - Accepting Young Adult and Juvenile Patients, Ann Arbor
RekruttererFase 2/3
Alder 6 til 75 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06154252Daratumumab in Primary Antiphospholipid Syndrome
- University of Michigan, Ann Arbor
RekruttererFase 1/2
Alder 18 til 65 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT05671757RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- University of Michigan, Ann Arbor
RekruttererFase 2/3
Alder 18 til 75 · Alle kjønn · Oppdatert 17. aug. 2026 · NCT06328777A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- University of Michigan, Ann Arbor
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT06056297Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1026, Detroit
- Site Number - 1005, East Lansing
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 30. jul. 2026 · NCT07039916A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Michigan, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Henry Ford Health System, Detroit
- og 2 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Karmanos Cancer Institute, Detroit
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 25. feb. 2026 · NCT06626919Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.